SB 1034 – Idaho
Status: Inactive / DeadYear Introduced: 2019
Link: https://legislature.idaho.gov/sessioninfo/2019/legislation/S1034/
Adds to existing law to provide that anticancer medications that are self-administered by a patient shall not have a higher copayment, deductible, or coinsurance amount than injected or intravenously administered anticancer medications.
Key Issues:
PHARMACEUTICALS
Cost-Sharing or Out-of-Pocket Costs
Return to Database Search
© 2018- The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.
Associated Litigation:
No items found
Leave A Comment